Local News: Ashburn, VA 

 | 

Sign Up

 | 

Sign In

Pharmaceuticals

Pharmaceutical News Editors

News Widget

Display the Pharmaceuticals news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

Pharmaceutical News

Pharmaceuticals news continually updated from thousands of sources around the net.

1 hr ago | Seeking Alpha

Actavis To Increase Operational Synergies By Acquiring Warner

The pharmaceutical industry is one of the biggest industries in the world. Currently the global pharmaceutical industry is worth $300 billion a year, and expected to reach $400 billion in the coming few years.

Comment?

Related Topix: Biotech, Warner Chilcott, Healthcare Industry, Women's Health, Health, Colitis

5 hrs ago | The Columbus Dispatch

Plan would turn old German Village school into enormous residence

The building at 673 Mohawk St. hasn't been used as a school since 1968. It hasn't made it as a commercial property.

Comment?

Related Topix: Biotech, Cardinal Health, Medicine, Healthcare Industry, Allegiance, Columbus, OH, Bexley, OH

Thu May 23, 2013

Scoop

NZ Pharmaceutical Expert to Collaborate with UC Researchers

A leading New Zealand pharmaceutical scientist has been lecturing University of Canterbury chemistry students and looking at collaborating with UC researchers.

Comment?

Insider Monkey

McKesson Corporation (MCK): Insiders Aren't Crazy About It

MCK shareholders have witnessed a decrease in support from the world's most elite money managers of late.

Comment?

Related Topix: Biotech, Medicine, McKesson, Household Products, Healthcare Industry

Insider Monkey

Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Hedge Funds and...

Teva Pharmaceutical Industries Ltd was in 47 hedge funds' portfolio at the end of March.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Healthcare Industry

Freshnews

Takeda Initiates TOURMALINE-MM2 Pivotal Phase 3 Trial of MLN9708 in...

Takeda Pharmaceutical Company Limited today announced the initiation of an international phase 3 clinical trial evaluating once a week MLN9708 in combination with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma who are not candidates for transplant.

Comment?

Related Topix: Takeda Pharmaceutical Company, Millennium Pharmaceuticals, Oncology, Medicine

Washington Times

Wall Street has a Wile E. Coyote moment

WASHINGTON, May 23, 2013 The mood is grim on Wall Street this morning after yesterday's double whammy.

Comment?

Related Topix: Financial Markets, Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Bristol-Myers Squibb, Healthcare Industry

AmericanBankingNews.com

Bayer AG's Neutral Rating Reaffirmed at BNP Paribas

's stock had its "neutral" rating reiterated by equities research analysts at BNP Paribas in a research note issued to investors on Thursday, Analyst Ratings.Net reports.

Comment?

Related Topix: e-Spirit, Bayer AG, Manufacturing, Biotech, Chemicals

AmericanBankingNews.com

Bayer AG Coverage Initiated at Morgan Stanley

Shares of Bayer AG opened at 109.20 on Thursday. Bayer AG has a 52 week low of $59.57 and a 52 week high of $107.94. The stock's 50-day moving average is currently $103.1. The company has a market cap of $90.303 billion and a P/E ratio of 27.20. A number of other analysts have also recently weighed in on BAYRY.

Comment?

Related Topix: Stanley, e-Spirit, Bayer AG, Manufacturing, Biotech, Chemicals

PR-inside.com

Water Analytical Instruments Market in China to Reach Up to USD 550...

The main reasons for growth for analytical instruments in China include flourishing pharmaceutical industry along with the increasing focus towards wastewater treatment.

Comment?

BioSpace

Cardinal Health, Inc. Release: New Research Proves Clinical Pathways...

Cardinal Health, Inc. Release: New Research Proves Clinical Pathways Can Reduce Cancer Care Costs and Improve Quality While Increasing Physician Reimbursement by 20201, many in the healthcare industry are looking for ways to curb that cost curve while maintaining quality of care for cancer patients and preserving fair compensation for physicians.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Cardinal Health, Oncology

Wed May 22, 2013

AmericanBankingNews.com

McKesson Co. Announces Quarterly Dividend of $0.22

McKesson declared a quarterly dividend on Wednesday, May 22nd, AnalystRatingsNetwork reports.

Comment?

Related Topix: McKesson, Biotech, Household Products, Medicine, Healthcare Industry

Live Charts

US broker round-up

Top US stock recommendations of the day: ADVANCED MICRO DEVICES: Jefferies & Co reiterates BUY rating.

Comment?

Related Topix: Advanced Micro Devices, Startups, Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Bristol-Myers Squibb, Healthcare Industry

Business Journal

KV reports $3.5 million loss for April

Bridgeton-based KV Pharmaceutical reported a net loss of $3.5 million for the month ended April 30, on revenue of $8.3 million, according to a recent filing with the U.S. Securities and Exchange Commission .

Comment?

Related Topix: KV Pharmaceutical, Biotech, Medicine, Healthcare Industry, Securities and Exchange Commission, Corporate / Securities Law, Law, US Securities and Exchange Commission, Financial Services, Economics News, Bankruptcy

AME Info

Forex shortage cripples Syrian pharmaceutical industry

A shortage of foreign currency has brought Syria's pharmaceutical industry production to a near halt, AFP has reported.

Comment?

Related Topix: Middle East, Syria, World News

Reuters

Immune system cancer drugs tipped to be a $35 bln market

A new wave of medicines that tap the power of the immune system to fight cancer could become the biggest drug class in history, with potential sales of $35 billion a year.

Comment?

Related Topix: Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Bristol-Myers Squibb, Healthcare Industry, Healthcare Law, Law

Drug Researcher

Impax Hires Specialists to Help Sort Manufacturing Issues

Faced with manufacturing quality questions that caused the FDA to reject its potential Parkinson's disease treatment, Impax Laboratories has hired a committee of specialists to oversee quality improvements at its California facility.

Comment?

Related Topix: Biotech, Impax Laboratories, Medicine, Healthcare Industry, Parkinson's Disease, Health, Hayward, CA

Tue May 21, 2013

BioSpace

IMPAX Laboratories, Inc. Board Steps in to Oversee Hayward Manufacturing Issues

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! HAYWARD, Calif.

Comment?

Related Topix: Biotech, Impax Laboratories, Medicine, Healthcare Industry, Startups, Hayward, CA, Food and Drug Administration, Watson Pharmaceuticals, Marketing

The Washington Post

Teva Bets on Reformulating Drugs as Investors Say - Show Me'

Teva Pharmaceutical Industries Ltd., which just two years ago was analysts' highest-rated stock among the world's 20 biggest drugmakers, is struggling to convince investors that a key part of its strategy will revive growth.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Healthcare Industry, Health, Pain, New York, Sanford C. Bernstein, Bristol Myers Squibb

Business Journal

Court rules in favor of Mylan in patent case

An appellate court has upheld five patents for Mylan Specialty L.P., reversing a district court's summary judgment affecting the company's Perforomist medication, which is used to treat breathing problems.

Comment?

Related Topix: Dey, Biotech, Startups, Medicine, Mylan Laboratories, Healthcare Industry

Pharmaceuticals Jobs